Approximately 80% of the data in a typical health system’s clinical operation lives in unstructured form: physician notes, consult reports, discharge summaries, operative notes, radiology reports, pathology findings, and the endless narrative documentation that clinicians produce every day. Structured fields — diagnosis codes, medication lists, lab values — represent the remaining 20%. Every analytics initiative, every AI use case, every automation project that healthcare organizations attempt runs into the same wall: the answers live in the 80% that no downstream system can read. For decades, the response has been to hire humans to read the notes and manually extract what was needed. Clinical documentation specialists, coders, quality abstractors, research assistants — thousands of skilled people whose job is to translate clinician narrative into structured data that other systems can use. This is expensive, slow, error-prone, and impossible to scale.
Generative AI changes this equation for the first time. GenAI models can read a clinical note, understand what happened during the encounter, and produce structured output that reflects the clinical picture — diagnoses, comorbidities, medications, key findings, disposition, and dozens of other fields — in seconds. What used to require hours of skilled human reading now takes moments of model inference. The productivity implications are enormous. But so are the trust implications. The question every healthcare organization asks is the same: how do we know when to trust the output, and when not to?
The answer lies in the mechanics of how GenAI extraction actually works, what it does exceptionally well, where it predictably struggles, and how confidence scoring turns an inherently probabilistic system into an operationally reliable one. Understanding these mechanics is what separates organizations that get durable value from GenAI extraction from those that deploy it, encounter an early failure, and abandon it before the technology matures.
How the Extraction Pipeline Works
A clinical note enters the pipeline as unstructured text, either directly from the EHR or from a document processing upstream step. The GenAI model has been given a specific extraction schema — the set of fields the operation wants populated from every note of this type. The model reads the note in full, understanding both the explicit statements and the implicit clinical reasoning connecting them. It produces a structured output that maps to the schema: primary diagnosis, secondary diagnoses, medications with doses, key findings, procedures performed, disposition, and whatever other fields are needed. Alongside each extracted value, the model produces a confidence score reflecting how certain it is that the extraction is correct.
The confidence score is the mechanism that makes the entire pipeline safe at scale. High-confidence extractions — scores of 0.95 and above — flow directly to downstream systems: analytics warehouses, coding queues, denial prevention engines, quality registries. Medium-confidence extractions might be routed for spot-check review by a human before flowing downstream. Low-confidence extractions get flagged for full human review with the specific ambiguity highlighted. The model, in effect, knows what it doesn’t know, and it uses that self-knowledge to route work appropriately. Without this discipline, GenAI extraction is dangerous. With it, GenAI extraction is one of the most productive capabilities healthcare has ever deployed.
The pipeline also includes a feedback loop that most organizations underinvest in. When a human reviews a low-confidence extraction and produces the correct answer, that correction becomes training signal for future model improvement. Over months, the model gets better at the specific documentation patterns of your organization, your specialty mix, and your local clinical language. This organizational learning is a strategic asset. It means the model deployed at your organization becomes progressively more useful over time, in ways a generic model cannot match. It also means that data governance around the training feedback loop matters — organizations that treat corrections as ephemeral fixes miss the opportunity to build a model that genuinely learns their operation.
What It Gets Right: Specific, Well-Documented Cases
GenAI extraction excels when the underlying documentation is specific and complete. A cardiologist documenting a STEMI patient writes something like: 62-year-old male presenting with 2-hour crushing chest pain radiating to left arm, history of hypertension and type 2 diabetes on metformin, EKG showing ST elevation in V2-V4, troponin of 4.2, diagnosis of STEMI, cath lab activated. Every clinically relevant fact is stated explicitly. The GenAI model reads this and produces high-confidence extractions across every field: primary diagnosis STEMI (I21.0) at 0.98 confidence, comorbidities hypertension and type 2 diabetes and hyperlipidemia at 0.95, medications metformin 500mg BID at 0.97, key findings ST elevation V2-V4 and troponin 4.2 at 0.94, disposition cath lab activation at 0.96.
This is not just character recognition or field extraction. The model understands that ST elevation in V2-V4 is anterior-territory information, that troponin 4.2 is significantly elevated, that these findings support the STEMI diagnosis, and that cath lab activation is the appropriate disposition for this clinical picture. It’s producing structured data that reflects clinical meaning, not just surface facts. When documentation is this specific, GenAI extraction is not just accurate — it is more consistent than human abstraction, faster than human abstraction by three orders of magnitude, and dramatically cheaper. This is the case that makes the business case for GenAI extraction work.
Where It Errs: Ambiguous or Underdocumented Cases
The failure modes of GenAI extraction are equally predictable. Consider a follow-up note from a primary care visit: patient seen for follow-up, reports feeling off for several days, some shortness of breath with exertion, mild edema, medications reviewed, possible early congestive heart failure versus medication side effect versus deconditioning, will trial a diuretic and follow up in two weeks. This note is ambiguous by design — the clinician is expressing diagnostic uncertainty because the clinical picture doesn’t yet support a definitive diagnosis. The GenAI model reads this and correctly reflects the ambiguity in its output: primary diagnosis possible early CHF at 0.42 confidence, alternate differentials at 0.35, medications reviewed but unclear which medications at 0.31.
This is the pipeline working correctly, not failing. The low confidence scores signal to downstream systems that this extraction should not flow to analytics or claims without human review. What the model has done is exactly what it should do: it has extracted what can be extracted, flagged what is ambiguous, and routed the note for clinician clarification. A less-disciplined system would produce a confident-looking CHF diagnosis code from an ambiguous note, feeding a downstream billing or quality reporting system with fabricated certainty. The confidence-scored approach protects against this specific failure mode by refusing to project certainty the documentation does not support.
Where It Should Not Be Used at All
Not every clinical extraction use case is appropriate for GenAI, even with confidence scoring in place. Direct clinical decision support — where the extraction feeds a system that recommends a treatment or alerts to a diagnosis in real time — probably needs different tooling than general-purpose GenAI extraction. The confidence bar is higher, the regulatory scrutiny is greater, and the failure cost is measured in patient outcomes rather than downstream data quality. Similarly, extractions that feed regulatory reporting where the output is legally attested to by the organization deserve special caution. The model output should be reviewed by qualified humans as a matter of policy, even when confidence is high, because the accountability structure demands it.
There is also a category of edge cases where GenAI extraction is simply not the right tool: handwritten notes with poor legibility, notes in languages the model was not trained on, dictated notes with significant transcription errors, and notes that reference external documents the model does not have access to. These cases do not benefit from a probabilistic extraction system; they benefit from human review or from upstream fixes to the documentation quality. Trying to force GenAI extraction into these cases produces the low-quality outputs that damage the reputation of the entire program. Successful deployments include explicit inclusion criteria and route out-of-scope documents to human abstractors rather than pretending the AI can handle them.
The Discipline of Confidence Scoring
Confidence scoring is not a nice-to-have feature of GenAI clinical extraction; it is what makes the technology safe to deploy. Every organization deploying GenAI extraction needs to answer three questions before production. What confidence threshold routes to automatic downstream use? What threshold routes to human review? What happens to extractions below the review threshold? These thresholds should not be picked by the vendor and applied uniformly. They should be picked by the organization, calibrated by use case, and revisited on a regular cadence based on production outcomes.
A quality registry extraction can safely auto-flow at 0.90 because errors get caught in downstream data quality processes. A billing code extraction probably needs 0.97 because errors flow directly into claims and compliance risk. A clinical decision support extraction likely needs 0.99 or is not appropriate for GenAI at all. Setting these thresholds by use case is the discipline that separates GenAI programs that deliver operational value from GenAI programs that deliver operational risk. When the thresholds are right, the pipeline handles 80-90% of extractions with no human involvement while flagging the remaining 10-20% for the exact review they need. When the thresholds are wrong in either direction, the system either produces silent errors or generates so many review queue items that the productivity gains evaporate.
What Documentation Quality Does to the Numbers
The single largest predictor of GenAI extraction success in a healthcare organization is not the model. It is the quality of the clinical documentation the model has to read. Organizations with strong documentation cultures — where physicians write specific, complete notes because they understand how those notes will be used downstream — see GenAI extraction accuracy in the mid-to-high 90s and straight-through processing rates above 80%. Organizations with weaker documentation cultures see accuracy in the 70s and straight-through processing rates below 50%, not because the AI is worse but because the documentation is more ambiguous. This has an important strategic implication. Deploying GenAI extraction creates immediate pressure on documentation quality. Physicians see the specific ways their notes were interpreted, discover that ambiguous documentation produces ambiguous extractions, and start writing more precisely. Over 12-18 months, documentation quality improves measurably in organizations that have deployed GenAI extraction, which in turn improves extraction accuracy, which further reinforces documentation habits. The virtuous cycle is real. But it does mean that early results — the first three to six months of deployment — will reflect current documentation quality, which is usually not great. Executive teams that expect immediate 95%+ accuracy across every note type will be disappointed. Executive teams that expect the technology to reveal documentation gaps and drive their systematic improvement will get exactly what they came for. The organizations that treat GenAI extraction as a documentation quality program disguised as an efficiency program are the ones that capture the compounding value the technology makes possible over time.
About BTCNXT
BTCNXT builds GenAI clinical data structuring pipelines with confidence-scored extraction and calibrated human review workflows. We help clinical, informatics, and RCM leaders turn 80% of their unstructured clinical data into operationally reliable structured records — safely, at scale.
